Clarissa Widyantoro

Ms. Clarissa Widyantoro

Natural Sciences and Science Education, National Institute of Education, Nanyang Technological University, Singapore, Central Singapore, Singapore
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2025 in Journal of Chemical Education
Verified
Journal Article
Open access
CWClarissa Widyantoro
Clarissa Widyantoro
JHJia Yi Han
Jia Yi Han
JOJonathan Sing Huat Ong
Jonathan Sing Huat Ong
KGKien Huay Goh
Kien Huay Goh
FFFun Man Fung
Fun Man Fung

24 April 2024 in Analytical Chemistry
Verified
Journal Article
Closed access
FFFun Man Fung
Fun Man Fung
CWClarissa Widyantoro
Clarissa Widyantoro
Sam Fong Yau LiSam Fong Yau Li
Sam Fong Yau Li

18 March 2026 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
HCHartono Candra
Hartono Candra
XWXue‐Jiao Wang
Xue‐Jiao Wang
KGKa Diam Go
Ka Diam Go
LFLi Feng
Li Feng
MCMiaomiao Cai
Miaomiao Cai
ZLZhao-Xun Liang
Zhao-Xun Liang
4‐Amino‐2,4‐pentadienoate‐containing cyclolipodepsipeptides (APD‐CLDs) represent a structurally distinctive family of natural products known for their selective activity against hypoxic cancer cells. To explore the structural diversity of APD‐CLDs, we have identified and prioritized cryptic APD‐CLD biosynthetic gene clusters (BGCs) for compound discovery. Using a combination of genetic and chemical methods, we successfully activated three dormant BGCs, leading to the discovery of 12 new APD‐CLDs. These newly discovered metabolites significantly expanded the diversity of the APD‐CLD family, with chloromalamides and arabimalamides representing the first halogenated and glycosylated members, respectively. Unexpectedly, chloromalamides and arabimalamides exhibited potent antiplasmodial activity, with IC 50 values in the 25–161 nM range against drug‐sensitive and multidrug‐resistant Plasmodium falciparum strains. Phenotypic studies revealed arabimalamide B halted parasite development during the asexual blood stage life cycle, resulting in enlarged digestive vacuoles, dispersed hemozoin, and ultimately reduced reinvasion efficiency. These phenotypes are reminiscent of the effect of chloroquine and other 4‐aminoquinoline drugs, suggesting that arabimalamides may disrupt the parasite's heme detoxification mechanism. Biosynthetic studies identified key scaffold‐forming and modifying enzymes, including a rare membrane glycosyltransferase in arabimalamide biosynthesis. Together, these findings unveil APD‐CLDs as new antimalarial lead scaffolds and set the stage for structural diversification and optimization.

9 March 2026 in Molecules
Verified
Journal Article
Open access
PDF file
LTLik Tong Tan
Lik Tong Tan
CWClarissa Widyantoro
Clarissa Widyantoro
NHNovriyandi Hanif
Novriyandi Hanif
Southeast Asia (SEA) harbors one of the world’s richest reservoirs of marine biodiversity, offering immense potential for natural product discovery. This review presents a comprehensive survey of sponge-derived marine natural products (MNPs), with notable activity, reported from SEA over the past two decades, highlighting their chemical diversity, biological activities and regional research trends. Analysis of the past two decades of MNPs data reveals that sponges (Phylum Porifera) remain the dominant source of new MNPs, representing nearly half of all discoveries in the region. Indonesia, Vietnam, and Thailand are leading contributors, with Indonesia exhibiting the highest productivity but limited local research leadership. The South China Sea and Indonesian archipelagos emerge as biodiversity and bioprospecting hotspots, yet large areas remain underexplored. Bioactive metabolites isolated from SEA sponges demonstrate potent anticancer, antimicrobial, anti-inflammatory, antiviral and enzyme-inhibitory properties, underscoring their value for pharmaceutical innovation. Despite this promise, uneven research capacity, infrastructure gaps and environmental degradation constrain sustainable exploitation. By consolidating recent advances in lead compound development and identifying key taxonomic as well as geographic priorities, this review strengthens the scientific foundation for marine drug discovery in SEA and supports integration of bioprospecting with regional Blue Economy and biodiversity conservation agendas and programs.

19 February 2026 in Synlett
Verified
Journal Article
Closed access
PDF file
YTYong Chua Teo
Yong Chua Teo
ATAnthia Shun Ai Teo
Anthia Shun Ai Teo
CWClarissa Widyantoro
Clarissa Widyantoro
JWJun Yan Wong
Jun Yan Wong
A general copper(I) chloride (CuCl) catalyst system was developed for the N-arylation of benzotriazoles using substituted aryl iodides under ligand-free conditions. Herein, 20 mol% CuCl was used to synthesise N-aryl benzotriazole derivatives in moderate to good yields. The practicality and low cost of this method make it well suited for both academic research and large-scale industrial applications.

1 October 2025
Verified
Book Chapter
Closed access
PDF file
LTLik Tong Tan
Lik Tong Tan
CWClarissa Widyantoro
Clarissa Widyantoro
NHNovriyandi Hanif
Novriyandi Hanif